Explore
Premium
Sign Up
Log In
CRT 2017 : RENAL DENERVATION & HYPERTENSION THERAPIES - Trial Design Part II & Future Directions
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
RENAL DENERVATION & HYPERTENSION THERAPIES - Trial Design Part II & Future Directions
Featuring
Michael Weber
Thomas Luescher
Hiren Mistry
Felix Mahfoud
Atul Pathak
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
What Is the Optimal Device Trial Design for Hypertension Therapy? - Michael Weber
Is There an Unmet Need for Device Treatment for Moderate Hypertension? - Thomas Luescher
What Are the Primary Endpoints for Controlling Hypertension? Unattended or Attended Office, Ambulatory or Home BP? - Felix Mahfoud
US Preventive Services Task Force Recommendation on ABPM Rationale/Potential Implications - Michael Weber
How Do I Treat Today’s Patients With Resistant Hypertension in My Practice? - Thomas Luescher
Future Directions for Treatment of Hypertension - Atul Pathak
Target Audience
Learning Objectives
Related Moments
CRT 2017 : FDA VALVE - Percutaenous Aortic Valves: Knowledge Gaps in a Maturing Technology
Conference
CRT 2016 Coronary - Antiplatelet Controversies for ACS: How Will They Impact Our Practice?
Conference
Antiplatelet Controversies for ACS: 'How Will They Impact Our Practice?' at CRT 2016
CRT 2016 Technology & Innovation - Japan-US Synergies: Bioresorbable Stent, Novel Coronary Devices, Unsolved Issues and Challenges
Conference
Japan-US Synergies: Bioresorbable Stent, Novel Coronary Devices, Unsolved Issues and Challenges at CRT 2016
Loading Simple Education